Navigation Links
CORD:USE Cord Blood Bank Congratulates Team Member Hal Broxmeyer, Ph.D., on his Election as President of the American Society of Hematology
Date:1/28/2010

ORLANDO, Fla., Jan. 28 /PRNewswire/ -- CORD:USE Cord Blood Bank congratulates CORD:USE team member and highly esteemed advisor Hal Broxmeyer, Ph.D., on becoming the 2010 President of the American Society of Hematology ("ASH").

"Being elected as President of such an important organization as ASH is a tremendous achievement and a testament to the pioneering research and body of work that Dr. Broxmeyer has performed, and we are deeply honored to have him as an integral member of our team," said CORD:USE President and CEO Edward Guindi, M.D.  

The American Society of Hematology is the world's largest professional society, with more than 16,000 members from 97 countries, concerned with the causes and treatments of blood disorders.  The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

Dr. Broxmeyer is internationally recognized as a founder of the field of umbilical cord blood stem cell transplantation.  He helped start the first cord blood banking company and was involved in planning and coordinating the first successful cord blood transplant performed in 1988.  He set up the first proof-of-principal cord blood bank, which supplied the first five cord blood collections for HLA-matched sibling cord blood transplants.  As a result of the research of Dr. Broxmeyer and his colleagues, cord blood has been used in transplantation therapy for more than 16,000 patients with over 70 life-threatening diseases, such as leukemia, lymphoma, thalassemia, and sickle cell anemia.  

Dr. Broxmeyer is the Chairman of the Department of Microbiology and Immunology, former Director of the Walther Oncology Center and Mary Margaret Walther Professor Emeritus, Distinguished Professor of the Indiana University School of Medicine.  He is a member of the Cord Blood Committee of the National Marrow Donor Program ("NMDP") and has been a member of the Health Resources and Services Administration's ("HRSA") Advisory Council on Blood Stem Cell Transplantation.  In his more than 30 year career, he has authored over 600 publications and has served as an editor on many peer reviewed journals.  Dr. Broxmeyer has won numerous awards, including the highly prestigious E. Donnall Thomas Prize from ASH.  

About CORD:USE Cord Blood Bank

CORD:USE Cord Blood Bank, headquartered in Orlando, Florida, is creating a large, ethnically diverse, high quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant.  CORD:USE has assembled a team of world leaders in the field of cord blood banking and transplantation.  CORD:USE has entered into agreements with hospitals across the country to provide mothers the option to donate their babies' cord blood.  CORD:USE makes these cord blood units available to transplanters throughout the country and around the world, as a critical component in their patients' treatment.  CORD:USE is accredited by the Foundation for the Accreditation of Cellular Therapy ("FACT") and lists all of its units on the National Marrow Donor Program's Registry.  CORD:USE has also been selected by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health as one of the high quality cord blood banks to build the federally supported National Cord Blood Inventory.  For more information, please visit www.corduse.com.

SOURCE CORD:USE Cord Blood Bank

RELATED LINKS
http://www.corduse.com

'/>"/>

SOURCE CORD:USE Cord Blood Bank
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
4. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
5. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. BioMosaics Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
8. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in Miami
9. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
10. Microlifes Home Blood Pressure Monitors Proven Accurate Even for Critical Patients
11. WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
(Date:7/12/2017)... INDIANAPOLIS , July 12, 2017  Eli Lilly and ... settlement agreement with generic companies to resolve pending patent litigation ... Virginia regarding the Cialis ® ... expire on April 26, 2020. As part of the agreement, ... on September 27, 2018. "The unit dose patent ...
Breaking Medicine Technology:
(Date:7/24/2017)... OH (PRWEB) , ... July 24, 2017 , ... ... place August 13-17 in National Harbor, MD. This year's theme focuses on the ... the principal benchmarks for quality and integrity in testing and calibration will be ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... A Southern ... food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: A ... in her life and how she has risen above. , In “Memories,” readers get ...
(Date:7/24/2017)... Church, VA (PRWEB) , ... July 24, 2017 ... ... and Managers, **Presented by FDAnews and MSceppa Consulting **, Aug. 22-23, 2017 – ... ends on Friday, July 28. , Increased FDA scrutiny and growing demands to ...
(Date:7/24/2017)... ... ... customizable and interactive Bible study guide for children. “The Perfect Gift” is the creation of ... accepted Christ as her Savior, yet never studied His word, surrendered to His will, or ... book to her children, so they would know the importance of the truth. She ...
(Date:7/24/2017)... ... 24, 2017 , ... The Center for Addiction Recovery Training ... host a second Multiple Pathways of Recovery Conference on October 23-26, 2017. This ... from CCAR’s foundational principle – a belief in multiple pathways of recovery, aims ...
Breaking Medicine News(10 mins):